THE OPTICAL ISOMERS OF THE 1,4-DIHYDROPYRIDINE BAY K-8644 SHOW OPPOSITE EFFECTS ON CA CHANNELS

被引:268
作者
FRANCKOWIAK, G [1 ]
BECHEM, M [1 ]
SCHRAMM, M [1 ]
THOMAS, G [1 ]
机构
[1] BAYER AG,PHARMA RES CTR,D-5600 WUPPERTAL 1,FED REP GER
关键词
D O I
10.1016/0014-2999(85)90631-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:223 / 226
页数:4
相关论文
共 10 条
[2]   SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].
FLECKENSTEIN, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166
[3]   CALCIUM CHANNELS - DIRECT IDENTIFICATION WITH RADIOLIGAND BINDING-STUDIES [J].
GLOSSMANN, H ;
FERRY, DR ;
LUBBECKE, F ;
MEWES, R ;
HOFMANN, F .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1982, 3 (11) :431-437
[4]   DIFFERENT MODES OF CA-CHANNEL GATING BEHAVIOR FAVORED BY DIHYDROPYRIDINE CA-AGONISTS AND ANTAGONISTS [J].
HESS, P ;
LANSMAN, JB ;
TSIEN, RW .
NATURE, 1984, 311 (5986) :538-544
[5]   SPECIFIC BINDING OF A CALCIUM-CHANNEL ACTIVATOR, [H-3]-LABELED BAY-K-8644, TO MEMBRANES FROM CARDIAC-MUSCLE AND BRAIN [J].
JANIS, RA ;
RAMPE, D ;
SARMIENTO, JG ;
TRIGGLE, DJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 121 (01) :317-323
[6]   DIHYDROPYRIDINE DERIVATIVES PROLONG THE OPEN STATE OF CA-CHANNELS IN CULTURED CARDIAC-CELLS [J].
KOKUBUN, S ;
REUTER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (15) :4824-4827
[7]   STUDIES ON THE MECHANISM OF ACTION OF THE VASOCONSTRICTIVE DIHYDROPYRIDINE, CGP-28392 [J].
LOUTZENHISER, R ;
RUEGG, UT ;
HOF, A ;
HOF, RP .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 105 (3-4) :229-237
[8]   REGULATION OF CARDIAC CALCIUM-CHANNEL CURRENT AND CONTRACTILE ACTIVITY BY THE DIHYDROPYRIDINE BAY K-8644 IS VOLTAGE-DEPENDENT [J].
SANGUINETTI, MC ;
KASS, RS .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1984, 16 (07) :667-670
[9]   NOVEL DIHYDROPYRIDINES WITH POSITIVE INOTROPIC ACTION THROUGH ACTIVATION OF CA-2+ CHANNELS [J].
SCHRAMM, M ;
THOMAS, G ;
TOWART, R ;
FRANCKOWIAK, G .
NATURE, 1983, 303 (5917) :535-537
[10]  
THOMAS G, 1984, CARDIOVASC PHARM, V6, P1170